Free Trial
NASDAQ:NBTX

Nanobiotix (NBTX) Stock Price, News & Analysis

Nanobiotix logo
$8.38 -1.47 (-14.92%)
Closing price 03:55 PM Eastern
Extended Trading
$8.51 +0.13 (+1.50%)
As of 04:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Nanobiotix Stock (NASDAQ:NBTX)

Key Stats

Today's Range
$8.37
$8.95
50-Day Range
$4.38
$10.09
52-Week Range
$2.76
$10.59
Volume
27,034 shs
Average Volume
12,040 shs
Market Capitalization
$401.76 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$8.00
Consensus Rating
Moderate Buy

Company Overview

Nanobiotix Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
15th Percentile Overall Score

NBTX MarketRank™: 

Nanobiotix scored higher than 15% of companies evaluated by MarketBeat, and ranked 871st out of 929 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Nanobiotix has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 1 buy rating, 1 hold rating, and no sell ratings.

  • Amount of Analyst Coverage

    Nanobiotix has received no research coverage in the past 90 days.

  • Read more about Nanobiotix's stock forecast and price target.
  • Percentage of Shares Shorted

    0.04% of the float of Nanobiotix has been sold short.
  • Short Interest Ratio / Days to Cover

    Nanobiotix has a short interest ratio ("days to cover") of 2.4, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Nanobiotix has recently increased by 209.84%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Nanobiotix does not currently pay a dividend.

  • Dividend Growth

    Nanobiotix does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.04% of the float of Nanobiotix has been sold short.
  • Short Interest Ratio / Days to Cover

    Nanobiotix has a short interest ratio ("days to cover") of 2.4, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Nanobiotix has recently increased by 209.84%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Nanobiotix has a news sentiment score of 1.31. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.70 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Nanobiotix this week, compared to 1 article on an average week.
  • Search Interest

    2 people have searched for NBTX on MarketBeat in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Nanobiotix insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 3.45% of the stock of Nanobiotix is held by insiders.

  • Percentage Held by Institutions

    Only 38.81% of the stock of Nanobiotix is held by institutions.

  • Read more about Nanobiotix's insider trading history.
Receive NBTX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Nanobiotix and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

NBTX Stock News Headlines

Guggenheim Reaffirms Their Buy Rating on Nanobiotix (NBTX)
“Sell Nvidia before earnings”
Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has been chasing the AI giant, Eric says its biggest customers are now its biggest competitors — and that could spell trouble ahead. Instead, he’s urging investors to consider a little-known hardware company that’s already starting to take off. In fact, while Nvidia has slipped over the past 30 days, this “off-the-radar” stock is up 18% — and Eric believes the run is just beginning.tc pixel
See More Headlines

NBTX Stock Analysis - Frequently Asked Questions

Nanobiotix's stock was trading at $2.87 at the beginning of the year. Since then, NBTX stock has increased by 205.9% and is now trading at $8.78.

Nanobiotix (NBTX) raised $95 million in an IPO on Friday, December 11th 2020. The company issued 6,500,000 shares at $14.69 per share. Jefferies, Evercore ISI, UBS Investment Bank and Gilbert DuPont acted as the underwriters for the IPO.

Shares of NBTX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Nanobiotix investors own include PayPal (PYPL), Sirius XM (SIRI), Ardelyx (ARDX), BridgeBio Pharma (BBIO), Cogent Communications (CCOI), Citius Pharmaceuticals (CTXR) and Datadog (DDOG).

Company Calendar

Today
8/26/2025
Next Earnings (Estimated)
9/17/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - DRUGS
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:NBTX
CIK
1760854
Fax
N/A
Employees
100
Year Founded
N/A

Price Target and Rating

High Price Target
$8.00
Low Price Target
$8.00
Potential Upside/Downside
-8.9%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
2 Analysts

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.04
Quick Ratio
1.04

Sales & Book Value

Annual Sales
-$11.61 million
Price / Sales
-36.26
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($1.51) per share
Price / Book
-5.81

Miscellaneous

Outstanding Shares
47,943,000
Free Float
46,289,000
Market Cap
$420.94 million
Optionable
Not Optionable
Beta
0.45

Social Links

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

This page (NASDAQ:NBTX) was last updated on 8/26/2025 by MarketBeat.com Staff
From Our Partners